Septic shock is associated with receptor for advanced glycation end products ligation of LPS Y Yamamoto, A Harashima, H Saito, K Tsuneyama, S Munesue, ... The Journal of Immunology 186 (5), 3248-3257, 2011 | 247 | 2011 |
Chromatin binding of FOXA1 is promoted by LSD1-mediated demethylation in prostate cancer S Gao, S Chen, D Han, Z Wang, M Li, W Han, A Besschetnova, M Liu, ... Nature Genetics 52 (10), 1011-1017, 2020 | 99 | 2020 |
Reactivation of androgen receptor-regulated lipid biosynthesis drives the progression of castration-resistant prostate cancer W Han, S Gao, D Barrett, M Ahmed, D Han, JA Macoska, HH He, C Cai Oncogene 37 (6), 710-721, 2018 | 98 | 2018 |
Androgen Receptor Tumor Suppressor Function Is Mediated by Recruitment of Retinoblastoma Protein S Gao, Y Gao, HH He, D Han, W Han, A Avery, JA Macoska, X Liu, ... Cell Reports 17 (4), 966-976, 2016 | 94 | 2016 |
Regulation of RAGE for attenuating progression of diabetic vascular complications MTT Win, Y Yamamoto, S Munesue, H Saito, D Han, S Motoyoshi, ... Journal of Diabetes Research 2012 (1), 894605, 2012 | 77 | 2012 |
TMPRSS2-ERG activates NO-cGMP signaling in prostate cancer cells F Zhou, S Gao, D Han, W Han, S Chen, S Patalano, JA Macoska, HH He, ... Oncogene 38 (22), 4397-4411, 2019 | 51 | 2019 |
Effect of notoginsenoside R1 on hepatic microcirculation disturbance induced by gut ischemia and reperfusion WX Chen, F Wang, YY Liu, QJ Zeng, K Sun, X Xue, X Li, JY Yang, LH An, ... World journal of gastroenterology: WJG 14 (1), 29, 2008 | 44 | 2008 |
Induction of receptor for advanced glycation end products by insufficient leptin action triggers pancreatic β‐cell failure in type 2 diabetes D Han, Y Yamamoto, S Munesue, S Motoyoshi, H Saito, MTT Win, ... Genes to Cells 18 (4), 302-314, 2013 | 40 | 2013 |
Forkhead domain mutations in FOXA1 drive prostate cancer progression S Gao, S Chen, D Han, D Barrett, W Han, M Ahmed, S Patalano, ... Cell research 29 (9), 770-772, 2019 | 39 | 2019 |
Validated Liquid Culture Monitoring System for Lifespan Extension of Caenorhabditis elegans through Genetic and Dietary Manipulations MTT Win, Y Yamamoto, S Munesue, D Han, S Harada, H Yamamoto Aging and disease 4 (4), 178, 2013 | 28 | 2013 |
RB1 loss in castration-resistant prostate cancer confers vulnerability to LSD1 inhibition W Han, M Liu, D Han, M Li, AA Toure, Z Wang, A Besschetnova, ... Oncogene 41 (6), 852-864, 2022 | 27 | 2022 |
ZBTB7A mediates the transcriptional repression activity of the androgen receptor in prostate cancer D Han, S Chen, W Han, S Gao, JN Owiredu, M Li, SP Balk, HH He, C Cai Cancer research 79 (20), 5260-5271, 2019 | 27 | 2019 |
cAMP ameliorates inflammation by modulation of macrophage receptor for advanced glycation end-products S Motoyoshi, Y Yamamoto, S Munesue, H Igawa, A Harashima, H Saito, ... Biochemical Journal 463 (1), 75-82, 2014 | 25 | 2014 |
LSD1 Inhibition Disrupts Super-Enhancer–Driven Oncogenic Transcriptional Programs in Castration-Resistant Prostate Cancer M Li, M Liu, W Han, Z Wang, D Han, S Patalano, JA Macoska, SP Balk, ... Cancer Research 83 (10), 1684-1698, 2023 | 23 | 2023 |
Exploiting the tumor-suppressive activity of the androgen receptor by CDK4/6 inhibition in castration-resistant prostate cancer W Han, M Liu, D Han, AA Toure, M Li, A Besschetnova, Z Wang, ... Molecular Therapy 30 (4), 1628-1644, 2022 | 18 | 2022 |
Lsd1 activates PI3K/Akt signaling through regulating p85 expression in prostate cancer cells Z Wang, S Gao, D Han, W Han, M Li, C Cai Frontiers in oncology 9, 721, 2019 | 15 | 2019 |
Protective effects of 3, 4-dihydroxyphenyl lactic acid on lipopolysaccharide-induced cerebral microcirculatory disturbance in mice YJ Li, D Han, XS Xu, YY Liu, K Sun, JY Fan, RQ Qian, JY Han Clinical hemorheology and microcirculation 50 (4), 267-278, 2012 | 14 | 2012 |
Increased AR expression in castration-resistant prostate cancer rapidly induces AR signaling reprogramming with the collaboration of EZH2 M Labaf, M Li, L Ting, B Karno, S Zhang, S Gao, S Patalano, JA Macoska, ... Frontiers in Oncology 12, 1021845, 2022 | 12 | 2022 |
A novel nonsense mutation in androgen receptor confers resistance to CYP17 inhibitor treatment in prostate cancer D Han, S Gao, K Valencia, J Owiredu, W Han, E de Waal, JA Macoska, ... Oncotarget 8 (4), 6796, 2017 | 12 | 2017 |
SETD7 functions as a transcription repressor in prostate cancer via methylating FOXA1 Z Wang, J Petricca, M Liu, S Zhang, S Chen, M Li, A Besschetnova, ... Proceedings of the National Academy of Sciences 120 (33), e2220472120, 2023 | 8 | 2023 |